Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Product 0405 (Desonate) in Pediatric Atopic Dermatitis
NCT01232543Phase 2Completed
- Sponsor
- Fougera Pharmaceuticals Inc.
- Start
- Nov 2010
- Primary completion
- Aug 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of desonide in atopic dermatitis (AD), sponsored by Fougera Pharmaceuticals Inc. Primary endpoint: Hypothalamic Pituitary Adrenal Axis Response to Cosyntropin at 4 weeks. Started Nov 2010; status: completed.
02
Drugs
desonide
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01232543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01232543.